Updates are available Correction dated 2021-10-04
Click to view Correction: https://doi.org/10.1038/s41588-021-00956-2
-
Authors
Sinnott-Armstrong, Nasa https://orcid.org/0000-0003-4490-0601
Tanigawa, Yosuke https://orcid.org/0000-0001-9759-157X
Amar, David https://orcid.org/0000-0002-9719-0837
Mars, Nina https://orcid.org/0000-0002-7259-5993
Benner, Christian
Aguirre, Matthew
Venkataraman, Guhan Ram
Wainberg, Michael
Ollila, Hanna M.
Kiiskinen, Tuomo https://orcid.org/0000-0002-6306-8227
Havulinna, Aki S.
Pirruccello, James P. https://orcid.org/0000-0001-6088-4037
Qian, Junyang
Shcherbina, Anna
,
Rodriguez, Fatima
Assimes, Themistocles L. https://orcid.org/0000-0003-2349-0009
Agarwala, Vineeta
Tibshirani, Robert
Hastie, Trevor
Ripatti, Samuli https://orcid.org/0000-0002-0504-1202
Pritchard, Jonathan K. https://orcid.org/0000-0002-8828-5236
Daly, Mark J.
Rivas, Manuel A. https://orcid.org/0000-0003-1457-9925
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (1K01HL144607, R01EB001988-21, R01HG008140, R01HG010140, 5U01 HG009080)
The Department of Defense through a National Defense Science and Engineering Grant and by a Stanford Graduate Fellowship
Funai Overseas Scholarship from the Funai Foundation for Information Technology and the Stanford University School of Medicine
Academy of Finland (#331671, #309643)
- License Information
-
More Information
Article History
Received: 15 July 2020
Accepted: 1 December 2020
First Online: 18 January 2021
Change Date: 4 October 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41588-021-00956-2
Competing interests
: The Board of Trustees of the Leland Stanford Junior University filed a US Provisional Application ‘Methods for diagnosis of polygenic diseases and phenotypes from genetic variation’ (serial no. 62/852,738) describing this work. J.K.P., M.A.R., N.S.-A. and Y.T. are designated as inventors of the patent. M.A.R. is on the SAB of 54gene and the computational advisory board for Goldfinch Bio and has advised BioMarin, Third Rock Ventures, MazeTx and Related Sciences. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.
